missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ GRL 0617

Catalog No. RD72805
Change view
Click to view available options
Quantity:
5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
RD72805 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. RD72805 Supplier Tocris Bioscience™ Supplier No. 7280/5*

Coronavirus PLpro inhibitor

GRL 0617 is a coronavirus papain-like protease (Plpro) inhibitor (IC50 values are 0.6 and 0.8 μM for SARS-COV and SARS-CoV-2 PLpro, respectively). Inhibits deubiquitination activity of SARS-CoV PLpro. Displays no inhibition of human deubiquitinating enzymes. Improves cell viability following SARS-CoV infection. Inhibits SARS-CoV-2 viral replication and induces antiviral immune signaling pathways following SARS-CoV-2 infection in CaCo-2 cells.

Specifications

Chemical Name or Material 5-Amino-2-methyl-N-[(1 R)-1-(1-naphthalenyl)ethyl]benzamide
CAS 1093070-16-6
Quantity 5 mg
Target Papain-like Protease Inhibitors
Molecular Formula C20H20N2O
Purity 0.98